Tickled Pink products on sale
in stores from the
6th September

Asda launched the Tickled Pink campaign back in 1996 to raise money to help improve the lives of people with breast cancer, both now and in the future. Entering its 14th year, Asda's Tickled Pink campaign benefits two breast cancer charities - Breast Cancer Care and Breast Cancer Campaign and since it started, our work has raised over £21 million.


Dr Andrew Collins

(University of Southampton)

Discovering new genes is difficult; they are hard to find unless the genetic information of a large number of people with breast cancer is compared with an equally large number of people without the disease.

Professor Collins will analyse genetic information from different studies to increase the evidence that a certain genes causes breast cancer. He will also be able to eliminate those that aren’t responsible for the disease.

The results from this research, combined with findings from previous studies, will improve understanding of the genetic causes of breast cancer and ultimately contribute to the development of effective treatments.


Professor Addington-Hall

Professor Julia Addington–Hall

(University of Southampton)

On diagnosis of breast cancer a patient may be offered several forms of treatment including chemotherapy and radiotherapy. However, side effects of treatments (such as pain and stiffness) can impair long term quality of life.

This project aims to understand what side effects are experienced following treatment and how healthcare professionals can best help them deal with these effects.


Professor Thomas Helleday

(Royal Marsden Hospital, Oxford)

During radiotherapy patients will receive several doses of radiation over a series of weeks. However Dr Somaiah, working with Professor Helleday, believes that the way breast cancer cells respond to radiation changes over the course of treatment.

This may be due to the cancer cells developing ways to repair the DNA damage caused by radiotherapy, meaning that later radiotherapy doses may not be as effective at killing cancer cells as those received at the beginning. Dr Somaiah aims to discover if breast cancer cells can adapt to avoid being treated by radiotherapy, and if so what is the best way to administer radiotherapy to ensure this resistance is minimised, making radiotherapy more effective.